MedX Health Launches SkinSecure™ to Bring Direct, Non-Invasive, Objective Biological Measurement to Skin Health Research
A cloud-based SaaS platform linking MedX’s native SIAscope imaging devices to CRO and sponsor workflows. Mapping collagen, melanin and haemoglobin in skin in around 30 seconds, without any need for biopsy. MISSISSAUGA, Ontario — MedX Health Corp. (TSXV: MDX) today announced the commercial launch of SkinSecure™, a cloud-based SaaS platform that links the Company’s native […]
Read the full article on the original site.
Read Full Article